This session will review long acting cabotegravir/rilpivirine (LA-CAB/RPV) including the drug classes, dosing, and administration. It will review the current evidence around its use in people who inject drugs (PWID) with comorbid HIV. The session will also describe in detail a current clinic's implementation of LA-CAB/RPV in PWID including in those not virally suppressed.
Learning Objectives:
Learners will be able to:
Recount the drug classes of HIV medication and what classes are available in injectable form
Describe the dosing and administration of LA-CAB/RPV in PWID
Explain the contraindications for use of LA-CAB/RPV in PWID
